The need for safety in the healthcare sector is extremely high. Medical devices must comply with the essential safety and performance requirements of Regulation (EU) 2017/745 (MDR). A comprehensive risk management system is required, which must be implemented, applied and maintained. A clear and simple risk management system is the basis for bringing a safe and high-quality product to the market.
The EN ISO 14971 standard, which is harmonized with the MDR, provides assistance in implementing a risk management system. However, as always, the devil is in the detail.
How exactly should the acceptance criteria for residual risks be defined in the risk management plan for a specific product? How can an overview of implementation and effectiveness all control measures be maintained? How can the overall residual risk be declared acceptable in the risk management report?
It is crucial how the risk management process interacts with the processes for post-market surveillance (PMS), product development and the clinical evaluation ((link zu Independent Clinical Evaluation expertise)). Only an integrated solution can ensure that the safety requirements for medical devices are met.
Axxos has a large expertise with the diverse requirements for risk management and implements these individually for each medical device or within the complete organization.